From December 2nd to 4th, 2025, the 23rd Pharma Asia 2025, Asia’s premier pharmaceutical industry event, was held in Karachi, Pakistan. Shanghai JSD New Medical Material Co., Ltd, a leading innovator in China’s medical new materials field, showcased its core product—high-performance co-fill caps for BFS (blow-fill-seal) infusion bottles—demonstrating its cutting-edge technology and superior solutions in primary pharmaceutical packaging to pharmaceutical companies, industry experts, and partners from around the world, garnering widespread attention and praise.
At this exhibition, Shanghai JSD focused on the concept of “safer, more reliable, and more efficient” pharmaceutical packaging. The company’s highlight was its BFS co-injection cap for infusion bottles, a key component developed for modern infusion preparations, especially high-value-added drugs with extremely high requirements for packaging compatibility and sealing integrity (such as nutritional solutions, antibiotics, and biological products). This product is refined using an advanced multi-layer co-injection molding process. By precisely controlling the injection molding of polymer materials with different properties (such as PP/PE/TPE), a single cap simultaneously possesses excellent physical strength, elastic sealing performance, superior chemical compatibility, and stable low-risk characteristics for puncture and shedding.
At the exhibition, technical experts from JSD explained in detail the core advantages of their co-injection cap products to visitors:
Firstly, it boasts excellent sealing integrity. The multi-layered structural design ensures a long-lasting and reliable seal between the bottle opening and the rubber stopper, effectively preventing leakage of contents and external contamination, and guaranteeing the sterility of the medicine during storage and transportation.
Secondly, it has excellent puncture performance. The puncture area is made of special elastomer material, which can minimize puncture force while ensuring convenient clinical use and significantly reduce the generation of insoluble microparticles, meeting the stringent requirements of pharmacopoeias of various countries for injectable products.
Third, broad compatibility: the materials undergo rigorous screening and verification, exhibiting excellent compatibility with the vast majority of BFS bottle materials and pharmaceutical solutions, ensuring the safety and stability of the drugs within their shelf life.
Fourth, improved production efficiency: the product design takes into account the high-speed filling and capping requirements of automated production lines, helping pharmaceutical companies optimize their production processes.
During the three-day exhibition, Shanghai JSD’s booth attracted numerous local and international pharmaceutical companies, buyers, and industry professionals from Pakistan. Visitors highly praised the technical expertise, reliability, and ability to solve real-world pain points demonstrated by the company’s co-injection cap products, and engaged in in-depth discussions with the JSD team regarding specific project needs, technical standards, and potential collaborations. Many clients expressed that as the pharmaceutical industry in Pakistan and surrounding regions continues to raise its standards for drug quality and safety, suppliers like JSD, which provide high-standard, customized packaging solutions, are becoming indispensable partners in their supply chains.
Through Pharma Asia 2025, Shanghai JSD New Medical Material Co., Ltd not only successfully showcased its innovative strength and professional image in the field of medical packaging materials, but also gained a deeper understanding of the latest developments and customer needs in the South Asian market. A company representative stated, “Pakistan and the entire Asian region are key markets for the rapid development of the healthcare industry. We are delighted to share our innovative achievements in BFS packaging caps here. Shanghai JSD will continue to invest in R&D, committed to providing safer and more advanced medical packaging solutions for global pharmaceutical customers, jointly safeguarding patient medication safety, and contributing to human health.”
This participation in the exhibition marks another solid step forward for Shanghai JSD in its internationalization journey, laying a good foundation for its further expansion into the South Asian and even global markets.
